Merrimack Pharmaceuticals, Inc.
NASDAQ:MACK
15.145 (USD) • At close May 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||
| Current Assets: | |||||||||||||||
| Cash & Cash Equivalents
| 5.989 | 19.439 | 14.203 | 14.038 | 16.58 | 20.079 | 93.441 | 21.524 | 185.606 | 35.688 | 65.086 | 37.714 | 50.454 | 30.713 | 58.387 |
| Short Term Investments
| 12.886 | 0 | 0 | 0 | 0 | 51.199 | 0 | 0 | 0 | 88.34 | 90.116 | 72.238 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 18.875 | 19.439 | 14.203 | 14.038 | 16.58 | 71.278 | 93.441 | 21.524 | 185.606 | 124.028 | 155.202 | 109.952 | 50.454 | 30.713 | 58.387 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 17.469 | 6.483 | 3.313 | 5.857 | 9.267 | 7.426 | 3.745 | 1.77 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0.102 | 14.554 | 3.717 | 0.101 | 0.101 | 0.132 | 0 | 0 | 0 |
| Other Current Assets
| 0.309 | 0.389 | 0.48 | 2.506 | 2.112 | 4.24 | 1.403 | 3.786 | 5.487 | 4.654 | 5.484 | 8.95 | 0 | 0 | 0 |
| Total Current Assets
| 19.184 | 19.828 | 14.683 | 16.544 | 18.692 | 76.102 | 95.046 | 57.435 | 201.394 | 132.096 | 166.644 | 128.301 | 65.589 | 36.288 | 61.511 |
| Non-Current Assets: | |||||||||||||||
| Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 2.269 | 6.467 | 15.765 | 21.915 | 14.502 | 13.364 | 6.297 | 6.206 | 7.458 | 6.491 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.605 | 3.605 | 3.605 | 3.605 | 3.605 | 3.605 | 3.605 | 3.605 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.977 | 7.355 | 7.725 | 8.045 | 9.175 | 9.495 | 9.815 | 10.135 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.582 | 10.96 | 11.33 | 11.65 | 12.78 | 13.1 | 13.42 | 13.74 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 7.428 | 10.551 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.004 | 0.008 | 0.066 | 0.232 | 1.39 | 2.744 | 5.262 | 0.701 | 0.611 | 0.728 | 0.759 | 1.596 | 0.404 | 0.411 | 0.414 |
| Total Non-Current Assets
| 0.004 | 0.008 | 0.066 | 0.232 | 1.39 | 12.441 | 22.28 | 24.048 | 33.486 | 26.56 | 25.773 | 20.673 | 19.71 | 21.289 | 20.645 |
| Total Assets
| 19.188 | 19.836 | 14.749 | 16.776 | 20.082 | 88.543 | 117.326 | 81.483 | 234.88 | 158.656 | 192.417 | 148.974 | 85.299 | 57.577 | 82.156 |
| Liabilities & Equity: | |||||||||||||||
| Current Liabilities: | |||||||||||||||
| Account Payables
| 0.074 | 0.188 | 0.12 | 0.123 | 0.271 | 1.034 | 2.887 | 3.384 | 5.049 | 2.51 | 1.889 | 24.936 | 4.656 | 1.44 | 2.27 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47.113 | 0 | 13.346 | 8.248 | 2.373 | 0.048 | 0.443 | 0.847 |
| Tax Payables
| 0 | 0 | 0 | 0 | 1.314 | 0.083 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36.226 | 50.137 | 59.275 | 9.336 | 9.35 | 7.837 | 6.916 | 5.47 |
| Other Current Liabilities
| 0.367 | 0.401 | 0.442 | 0.647 | 2.499 | 13.761 | 16.89 | 48.612 | 48.56 | 72.022 | 76.522 | 1.861 | 27.22 | 15.052 | 75.507 |
| Total Current Liabilities
| 0.441 | 0.589 | 0.562 | 0.77 | 2.77 | 14.795 | 19.777 | 88.222 | 103.746 | 111.142 | 57.734 | 38.52 | 26.151 | 16.325 | 84.094 |
| Non-Current Liabilities: | |||||||||||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 14.873 | 0 | 216.861 | 257.655 | 106.806 | 103.427 | 37.482 | 268.225 | 0.048 | 0.508 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.673 | 51.197 | 35.682 | 66.139 | 6.323 | 78.056 | 67.422 | 56.287 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.045 | 0.496 | 0.507 | 0.755 | 1.267 | 0.81 | 131.273 |
| Other Non-Current Liabilities
| 0 | 0.589 | 0 | 0 | 0 | 0.056 | 1.265 | 3.386 | 9.852 | 13.202 | 7.738 | 72.411 | 269.741 | 191.909 | 132.029 |
| Total Non-Current Liabilities
| 0 | 0.589 | 0 | 0 | 0 | 14.929 | 1.265 | 245.92 | 314.823 | 149.585 | 177.811 | 116.971 | 349.064 | 260.189 | 188.824 |
| Total Liabilities
| 0.441 | 0.589 | 0.562 | 0.77 | 2.77 | 29.724 | 21.042 | 334.142 | 418.569 | 260.727 | 235.882 | 155.491 | 375.215 | 276.514 | 272.918 |
| Equity: | |||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 1.343 | 1.342 | 1.334 | 1.334 | 1.334 | 1.334 | 1.334 | 1.302 | 1.159 | 1.067 | 1.025 | 0 | 0.118 | 0.111 | 17.364 |
| Retained Earnings
| -548.817 | -547.636 | -546.092 | -543.637 | -540.609 | -523.277 | -482.771 | -954.799 | -802.232 | -655.17 | -572.245 | -442.116 | -350.839 | -271.616 | -221.512 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0 | -0 | 0 | 0 | -0.009 | 0 | 0 | 0 | -0.074 | -0.024 | -0.038 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 566.221 | 565.541 | 558.945 | 558.309 | 556.587 | 580.771 | 577.721 | 702.377 | 617.145 | 552.037 | 527.779 | 435.637 | 60.231 | 51.541 | 13.386 |
| Total Shareholders Equity
| 18.747 | 19.247 | 14.187 | 16.006 | 17.312 | 58.819 | 96.284 | -251.12 | -183.928 | -102.14 | -43.465 | -6.517 | -290.49 | -219.964 | -190.762 |
| Total Equity
| 18.747 | 19.247 | 14.187 | 16.006 | 17.312 | 58.819 | 96.284 | -252.659 | -183.689 | -102.071 | -43.128 | -6.42 | -289.916 | -218.937 | -190.762 |
| Total Liabilities & Shareholders Equity
| 19.188 | 19.836 | 14.749 | 16.776 | 20.082 | 88.543 | 117.326 | 81.483 | 234.88 | 158.656 | 192.417 | 148.974 | 85.299 | 57.577 | 82.156 |